Abstract
The successful treatment of Hodgkin's lymphoma is one of the most impressive achievements of modern medicine. Today more than 90 % of patients without fever, weight loss, or night sweats (B symptoms) are cured with optimal treatment, and 60-70 % of those with B symptoms are cured as well. Fortunately, most patients do not have B symptoms at presentation. These cure rates have not been achieved without problems. Long-term complications of cure have interrupted the well-being of a sizeable fraction of survivors, and relapses-even late relapses-are still a problem. Current clinical research is focused on optimal noninvasive staging of disease, reducing the short- and long-term complications of treatment, and early diagnosis of serious long-term complications such as cardiac disease and second malignancies.
Original language | English |
---|---|
Title of host publication | Neoplastic Diseases of the Blood |
Publisher | Springer New York |
Pages | 985-1013 |
Number of pages | 29 |
ISBN (Print) | 9781461437642, 1461437636, 9781461437635 |
DOIs | |
Publication status | Published - Nov 1 2013 |
Keywords
- Chemotherapy
- Classification of Hodgkin's lymphoma
- Diagnosis of Hodgkin's lymphoma
- Staging
ASJC Scopus subject areas
- Medicine(all)